Back to Journals » Nature and Science of Sleep » Volume 5

Obstructive sleep apnea in children: a critical update

Authors Tan H, Gozal D, Kheirandish-Gozal L

Received 22 July 2013

Accepted for publication 8 August 2013

Published 25 September 2013 Volume 2013:5 Pages 109—123


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Hui-Leng Tan,1,2 David Gozal,1 Leila Kheirandish-Gozal1

1Sections of Pediatric Sleep Medicine and Pediatric Pulmonology, Department of Pediatrics, Comer Children's Hospital, Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA; 2Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK

Abstract: Obstructive sleep apnea (OSA) in children is a highly prevalent disorder caused by a conglomeration of complex pathophysiological processes, leading to recurrent upper airway dysfunction during sleep. The clinical relevance of OSA resides in its association with significant morbidities that affect the cardiovascular, neurocognitive, and metabolic systems. The American Academy of Pediatrics recently reiterated its recommendations that children with symptoms and signs suggestive of OSA should be investigated with polysomnography (PSG), and treated accordingly. However, treatment decisions should not only be guided by PSG results, but should also integrate the magnitude of symptoms and the presence or absence of risk factors and signs of OSA morbidity. The first-line therapy in children with adenotonsillar hypertrophy is adenotonsillectomy, although there is increasing evidence that medical therapy, in the form of intranasal steroids or montelukast, may be considered in mild OSA. In this review, we delineate the major concepts regarding the pathophysiology of OSA, its morbidity, diagnosis, and treatment.

Keywords: adenotonsillar hypertrophy, polysomnography, pathophysiology, morbidity, treatment, pediatric sleep disordered breathing

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]